CAR-Macrophages platform (Target-Based Screened CAR-Macrophages)

Chimeric Antigen Receptor–macrophage · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-Macrophages platform (Target-Based Screened CAR-Macrophages), covering 2026-02-13 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors [EARLY_Phase 1]

See pricing